• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: November 2022

Finance

Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences

November 30, 2022 Microbiome Times

BRISBANE, Australia – Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to invest $17.8m to acquire a […]

Editor's Choice

Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic

November 29, 2022 Microbiome Times

Proge Farm, an Italian pharmaceutical company, has made microbiome history with its recently approved therapeutic and will now be able to market its drug based on Lactobaccilus plantarum P 17630. The company obtained authorization from […]

Finance

Holobiome Acquires Microbiome Startup AsiaBiome

November 25, 2022 Microbiome Times

Holobiome and AsiaBiome announce that they have closed a transaction for the acquisition of AsiaBiome by Holobiome. This acquisition unites two innovative life sciences companies that are committed to finding solutions to promote health through […]

Finance

Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders

November 16, 2022 Microbiome Times

Eligo Bioscience announced the issuance by the US Patent and Trademark Office (USPTO) of the first patent in a wide family covering genetic engineering of a key skin microbiome species, Cutibacterium acnes, to support therapeutic […]

Finance

BiomeBank announces regulatory approval for donor derived microbiome drug

November 9, 2022 Microbiome Times

BiomeBank today announced the first regulatory approval for a donor derived microbiome drug product worldwide. The Therapeutic Goods Administration (TGA) approved BiomeBank’s product for restoration of gut microbiota in the treatment of recurrent Clostridioides difficile […]

Finance

SYNLAB and Microba expand strategic agreement on advanced gut microbiome test

November 7, 2022 Microbiome Times

SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut microbiomes, have expanded their strategic agreement to broaden geographic […]

Finance

Maximizing on the Skin Microbiome Movement

November 3, 2022 Microbiome Times

By 2028 the global skin care market is projected to near $145.82 billion1, #skincareproducts2 has two billion plus views and counting on TikTok, and Vogue’s 2022 skin care trends3 include “supporting the skin’s microbiome.” The fascination with skin […]

Pharma & Human Health

Lonza Launches New Capsule to Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine

November 3, 2022 Microbiome Times

Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, has launched an innovative new capsule solution for intestinal (enteric) drug delivery. The Capsugel® Enprotect™ capsule does not disintegrate during stomach transit and only […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • “Probiotics” Green-lit for market-usage by French Authorities
    January 25, 2023
  • Microbiome Drug Development: 2022 in Review
    December 30, 2022
  • Exclusive Interview with Ken Blount, VP Microbiome Research at Ferring Pharmaceuticals
    December 22, 2022
  • FDA Approves First Fecal Microbiota Product
    December 1, 2022
  • Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic
    November 29, 2022
sign up

Sign up to the Microbiome Times newsletter